» Articles » PMID: 26436654

Recruitment, Response Rates and Characteristics of 5511 People Enrolled in a Prospective Clinical Cohort Study: Head and Neck 5000

Overview
Date 2015 Oct 6
PMID 26436654
Citations 19
Authors
Affiliations
Soon will be listed here.
Citing Articles

Cancer-related pain in head and neck cancer survivors: longitudinal findings from the Head and Neck 5000 clinical cohort.

Bolnykh I, Patterson J, Harding S, Watson L, Lu L, Hurley K J Cancer Surviv. 2024; .

PMID: 38421499 DOI: 10.1007/s11764-024-01554-x.


Cancer-Related Fatigue in Head and Neck Cancer Survivors: Longitudinal Findings from the Head and Neck 5000 Prospective Clinical Cohort.

Sharp L, Watson L, Lu L, Harding S, Hurley K, Thomas S Cancers (Basel). 2023; 15(19).

PMID: 37835558 PMC: 10571913. DOI: 10.3390/cancers15194864.


Development of a Duplex Serological Multiplex Assay for the Simultaneous Detection of Epstein-Barr Virus IgA and IgG Antibodies in Nasopharyngeal Carcinoma Patients.

Schieber J, Pring M, Ness A, Liu Z, Hsu W, Brenner N Cancers (Basel). 2023; 15(9).

PMID: 37174042 PMC: 10177259. DOI: 10.3390/cancers15092578.


Study retention and attrition in a longitudinal cohort study including patient-reported outcomes, fieldwork and biobank samples: results of the Netherlands quality of life and Biomedical cohort study (NET-QUBIC) among 739 head and neck cancer....

Jansen F, Brakenhoff R, Baatenburg de Jong R, Langendijk J, Leemans C, Takes R BMC Med Res Methodol. 2022; 22(1):27.

PMID: 35065597 PMC: 8784000. DOI: 10.1186/s12874-022-01514-y.


Epigenetic biomarkers of ageing are predictive of mortality risk in a longitudinal clinical cohort of individuals diagnosed with oropharyngeal cancer.

Beynon R, Ingle S, Langdon R, May M, Ness A, Martin R Clin Epigenetics. 2022; 14(1):1.

PMID: 34980250 PMC: 8725548. DOI: 10.1186/s13148-021-01220-4.


References
1.
Ness A, Waylen A, Hurley K, Jeffreys M, Penfold C, Pring M . Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource: head and neck 5000. BMC Cancer. 2014; 14:973. PMC: 4301458. DOI: 10.1186/1471-2407-14-973. View

2.
Mehanna H, Paleri V, West C, Nutting C . Head and neck cancer--Part 1: Epidemiology, presentation, and prevention. BMJ. 2010; 341:c4684. DOI: 10.1136/bmj.c4684. View

3.
Duffy S, Ronis D, Valenstein M, Fowler K, Lambert M, Bishop C . Depressive symptoms, smoking, drinking, and quality of life among head and neck cancer patients. Psychosomatics. 2007; 48(2):142-8. DOI: 10.1176/appi.psy.48.2.142. View

4.
Mehanna H, West C, Nutting C, Paleri V . Head and neck cancer--Part 2: Treatment and prognostic factors. BMJ. 2010; 341:c4690. DOI: 10.1136/bmj.c4690. View

5.
Drugan C, Leary S, Mellor T, Bain C, Verne J, Ness A . Head and neck cancer in the south west of England, Hampshire, and the Isle of Wight: trends in survival 1996-2008. Br J Oral Maxillofac Surg. 2012; 51(1):19-24. DOI: 10.1016/j.bjoms.2012.02.013. View